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Asthma is a common chronic condition and there is evidence that its prevalence may be rising. The 
European Respiratory Health Survey (ECRHS) was planned to produce comparable data on asthma 
epidemiology in Europe. In Greece, in particular, a similar study has not been conducted previously and 
no epidemiological data are available on adult asthma prevalence. Furthermore, the role of air pollution 
in the pathogenesis of asthma is currently an issue of debate. Athens is a city with high air pollution, and 
a study of asthma epidemiology in this city may confirm or refute a possible link with the expression of 
asthma. A questionnaire developed by the ECRHS was sent to a random sample of 3533 households in 
Peristeri, an industrialized borough of Athens. Responses were received from 2774 households (response 
rate 78%). Of all the data on individual subjects, only those from 3325 adults aged 20-44 years 
were considered, according to the study protocol. The self-reported current prevalence of asthmatic 
attacks and asthma-like symptoms were as follows: asthma attack 2.4%, use of asthma medication 
2.1%, awakening by shortness of breath 5.6%, awakening by cough 17.8%, wheezing 15.8% and nasal 
allergies 18.4%. 
It is concluded that thle prevalence of asthma and related symptoms in this region of Athens is rather 
low, despite the high air-pollution levels in the city. 
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Introduction 
The prevalence of asthma in adults in Athens, 
Greece has not been estimated previously. This 
study presents the European Community 
Respiratory Health Survey (ECRHS) results for 
asthma and asthma-like symptom prevalence in 
this highly air-polluted area. Asthma prevalence 
was examined in adults aged 2044 years and 
children were not included. 
Asthma is a common chronic disease that can 
have a profound effect on quality of life. There 
is evidence that the prevalence and severity of 
asthma may be increasing world-wide (14). The 
reasons for this increase cannot be clearly 
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defined since the pathogenesis of asthma is 
linked to many possible inducing factors. Postu- 
lated explanations include higher allergen ex- 
posure owing to changes in housing styles (5), 
indoor and outdoor pollution (6;7), and under- 
diagnosis or undertreatment of asthma in the 
past. Athens is a city with high levels of air 
pollution. A comparison of asthma prevalence in 
this city with other less polluted regions might 
clarify whether air pollution can be implicated 
in the pathogenesis of asthma. Currently, how- 
ever, it is difficult to interpret and compare data 
from published studies because of the lack of a 
universally accepted definition of asthma and 
differences in survey methodology. 
The ECRHS was designed to produce data on 
asthma epidemiology in Europe using a stand- 
ardized questionnaire delivered to a defined 
population sample (S), so that data will be 
comparable. Many centres have participated in 
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FIG. 1. ECRHS Stage I Questionnaire. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
Have you had wheezing or whistling in your chest 
at any time in the last 12 months? 
If ‘no’ go to Question 2, if ‘yes’; 
1.1 Have you been at all breathless when the 
wheezing noise was present? 
1.2 Have you had this wheezing or whistling 
when you did not have a cold? 
Have you woken up with a feeling of tightness in 
your chest at any time in the last 12 months? 
Have you been woken up by an attack of short- 
ness of breath at any time in the last 12 months? 
Have you been woken by an attack of coughing 
at any time in the last 12 months? 
Have you had an attack of asthma in the last 12 
months? 
Are you currently taking any medicine (including 
inhalers, aerosols or tablets) for asthma? 
Do you have any nasal allergies including hay 
fever? 
What is your date of birth? 
What is today’s date? 
Are you male or female? 
the study world-wide. Athens is the southern- 
most European centre in the study. 
Materials and Methods 
The protocol used in the study has been 
described previously (8). Briefly, an urban area 
with administrative boundaries and a population 
of at least 150 000 people had to be selected. The 
initially selected sample size was big enough to 
obtain responses from at least 1500 men and 
1500 women aged 2044 years living in the study 
area. Children were not included. These people 
had to answer the ECRHS Stage I questionnaire 
(Fig. 1) containing questions about wheezing, 
chest tightness, shortness of breath, cough, 
asthma attacks, medication and nasal allergies. 
The 2044 years age group was chosen because 
all relevant symptoms are rarely due to chronic 
obstructive pulmonary disease. Congenital heart 
or lung disease may also be responsible for such 
symptoms, but their prevalence is low. 
In Athens, an industrialized borough with a 
population of 170 000 was selected. A highway 
runs through part of the area and there is a lot of 
heavy traffic as well as ordinary cars. Most 
centres participating in the ECRHS identified 
their sampling frame through registers including 
information on age, sex and address for each 
inhabitant in the selected area (electoral boards, 
general practitioner’s register etc.). In Athens, 
such registers do not necessarily include people 
living within a certain area. Therefore, another 
approach had to be taken, so electricity boards 
were used since they are specific to the area 
and all houses are equipped with electricity. A 
random sample was selected and questionnaires 
were sent to 3533 households accompanied by a 
letter explaining about the study and asking all 
people in the age range of 2044 years and living 
in the household to fill in the questionnaire. The 
initial response rate was low and non-responders 
were contacted again by home visits. Care 
was taken so that the subjects filled in the 
questionnaire without any interference from 
the investigator. 
Results from the questionnaire were entered 
into computer files and were statistically vali- 
dated by the co-ordinating centre and by the 
Greek group. Possible associations between the 
answers to any two questions were tested with 
the Pearson Chi-square statistic using the Systat 
R statistical package for Mackintosh. PcO.05 
was considered significant. 
Results 
RESPONSE RATES 
Response rates were based on households’ 
answers. From the 3533 households to which 
the questionnaire was initially mailed, only 552 
households responded (response rate 15.6%). 
The remaining 2981 households were contacted 
again by home visits. Of these, 422 houses were 
empty, and the people of 337 households denied 
to participate. Six hundred and fifty-four house- 
holds did not belong in the age range of 2044 
years but were included in the evaluation of 
response rates. Accordingly, the response to 
home visits was 74.5%. 
Unfortunately, the registers used did not con- 
tain information on age, so 66% of the respond- 
ing households contained people who were 
inside the age range for the ECRHS study, and 
34% of households contained people outside the 
age range. The 34% of households with people 
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FIG. 2. Distribution of selected households from 
the electricity board register. (a) Initially selected, 
(b) vacant during the study, (c) not willing to par- 
ticipate, (d) willing to participate, (e) households 
with individuals not within the age range, 
(f) participated in the study. 
TABLE 1. Asthma and asthma-like symptom preva- 
lence in Athens (%) 
Male Female Total 
Q 1 Wheezing 16.0 15.6 15.8 
Q2 Chest tightness* 9.5 13.3 11.6 
Q3 Breathlessness* 5.0 6.1 5.6 
Q4 Cough* 16.6 18.9 17.8 
Q.5 Asthma attack 2.0 2.8 2.4 
Q6 Asthma medication 2,l 2.2 2.1 
Q7 Nasal allergies 14.8 21.9 18.4 
*Awakened by. 
who did not belong in the appropriate age 
group could not be included in the evaluation of 
prevalence. They were, nevertheless, counted as 
responders because they wished to participate. 
Considering responses to mailing of the ques- 
tionnaire and home visits, the overall response 
rate is raised to 78.5%, based on household 
responses. Figure 2 shows the distribution of 
household answers. Finally, 1840 households 
took part in the study and the questionnaire was 
answered by a total of 3325 people, 2044 years 
old (1624 men and 1701 women), living in these 
households. 
PREVALENCE RATES 
Table 1 shows prevalence rates for asthma symp- 
toms, use of medication and nasal allergies as 
derived from the questionnaire. There was a 
trend for female preponderance in the prevalence 
TABLE 2. Prevalence rates (%) as calculated by mailing 
and home visits 
Home 
Mailing visits P 
Q 1 Wheezing 21.5 14.3 <0.0005 
Q2 Chest tightness” 18.1 9.9 <0.0005 
Q3 Shortness of breath” 9.7 4.5 <0.0005 
44 Cough* 21.2 16.9 co.01 
Q5 Asthma attack 5.3 1.6 <0.0005 
Q6 Asthma medication 3.7 1.7 <0~0001 
Q7 Nasal allergies 28.1 15.9 <0.0005 
*Awakened by. 
of most self-reported symptoms which reached 
statistical significance in Question 2 (Q2) (awak- 
ening by chest tightness) and Q7 (nasal allergies) 
(P<O.O004). Analysis of prevalence rates derived 
from the mailing of the questionnaire resulted in 
higher prevalence rates as compared with home 
visits and overall data analysis (Table 2). The 
prevalence of symptoms with respect to age was 
also examined. Prevalence in age groups 20-24, 
25-34 and 35544 years was estimated separately. 
With the exception of Q7, the frequency of 
positive answers to all of the questions increased 
proportionally with age (Fig. 3). Groups were 
balanced in terms of gender. 
Statistical analysis of the present data shows 
that, in relation to Q5 (asthma attacks), Q3 
(awakening by shortness of breath) and Q6 
(asthma medication) have higher x2 values 
(Q3, 732.6; Q6, 1700.6) than the remainder of 
the questions (Ql, 269.5; 42, 353~2; Q4, 156.1). 
Co-estimation of Q3, Q5 and Q6 increases the 
prevalence of asthma in Athens to 6.5%. 
Discussion 
This study showed a rather low prevalence of 
self-reported asthma and asthma-like symptoms 
in Athens, as compared with other centres in the 
study. Data from all centres are not yet avail- 
able, but results from ECRIIS in Sweden and 
Italy have been published and prevalence is 
higher than in Athens, as shown in Table 3 
(9,lO). Since there is no universally accepted 
definition of asthma, any or all the symptoms 
mentioned in the questionnaire of this study 
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FIG. 3. Prevalence of asthma and asthma-like 
symptoms in different age groups. Ql, wheezing (A), 
P<O.O005; 42, awakened by chest tightness (o), 
P=O.OOl; Q3, awakened by shortness of breath (+), 
P=O.OlS; Q4, awakened by cough (0), P~O.0453; 
Q5, asthma attack (m), P=O.O26; Q6, asthma medi- 
cation (O), P=O.O30; 47, nasal allergies (A), 
P=O.708. 
might be used for estimation of asthma preva- 
lence. This means that the true prevalence of 
asthma in any given region lies between the 
highest and the l.owest prevalence of referred 
positive answers in all relevant symptoms, and 
may, in fact, be higher than the prevalence of 
self-reported asthma. In the present study, the 
lowest prevalence was 2.1% for Q6 (asthma 
medication) and the highest prevalence was 
17.8% for Q4 (awakening by cough). Question 5 
(asthma attack) deals directly with asthma. Stat- 
istical analysis of these data shows that Q3 and 
Q6 are better correlated to Q5, having higher 
Chi-square values than the remainder of the 
questions. Considering Q3, Q5 and Q6 together, 
the prevalence of asthma in Athens increases to 
6.5%. Whether a similar phenomenon will be 
noted in other centres of the study remains to 
be seen. Long-term follow-up of people with 
TABLE 3. Overall observed prevalence rates (%) at 
ECRHS Stage I in Italy (Pavia, Turin, Verona), 
Sweden (Uppsala) and Greece (Athens) 
Italy Sweden Greece 
Q 1 Wheezing 9.9 19.0 15.8 
Q2 Chest tightness* 8.1 9.7 11.6 
Q3 Shortness of breath* 7.1 5.0 5.6 
Q4 Cough* 29.4 25.4 17.8 
Q5 Asthma attack 3.7 3.3 2.4 
Q6 Asthma medication 2.0 4.9 2.1 
Q7 Nasal allergies 15.9 22.2 18.4 
Results for Italy and Sweden are from de Marco et al. 
(9) and Bjornson et al. (lo), respectively. 
*Awakened by. 
positive answers to all questions will either 
confirm or reject the hypothesis that Q3, Q5 and 
Q6 are indeed better indicators of asthma. 
During the analysis of the present data, it was 
made obvious that the degree of response may 
affect prevalence rates. These results show that 
response rates are inversely related to prevalence 
rates. This has recently been shown in another 
ECRHS report from Italy (9). Epidemiological 
studies should have high response rates since low 
numbers of responses may include a higher 
percentage of answers from affected people. 
Mailing of questionnaires is a quicker and 
cheaper way for collection of data in epidemio- 
logical studies. However, care should be taken 
because affected subjects tend to respond more 
readily. Therefore, more expensive and time- 
consuming methods such as personal contact 
may be better indicated. 
The present data also show that self-reported 
symptoms become more frequent with age. This 
might reflect a true increase in asthma preva- 
lence since asthma may develop at any age, and 
new cases are added to the existing ones. It may 
also reflect the impact of environmental factors, 
such as smoking, on respiratory health. This is in 
accordance with data in the literature showing 
that mortality rates tend to be higher in the older 
asthmatics (2). However, increased mortality 
rate does not necessarily suggest increased 
asthma prevalence and it might also be due to 
other factors. 
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TABLE 4. Levels of air pollutants in Athens for winter and summer 
so2 Black smoke NO, 03 
24h @gmp3) 24h @gme3) 1 h &gm-3) 1h@gme3) 
%ax %nin Strnax %nin Stmax %nin Stmax Stmin 
Winter 106 (61) 31 (31) 141 (90) 64 (34) 170 (67) 64 (57) 82 (36) 34 (18) 
Summer 48 (26) 23 (15) 102 (60) 42 (23) 206 (85) 96 (55) 166 (59) 95 (33) 
Mean data (SD in parentheses). St,,,, Stmin: maximum and minimum mean levels for 
winter or summer. Source: Katsoyanni et al. (18). 
TABLE 5. Annual average levels of air pollution in Athens (mean values) 
Black smoke so, NO, 03 co 
24h @gm-3) 24h @gmp3) 1 h@gme3) 1h@gm-3) 1 h (mg nY3) 
55 36 54 47 3 
Data obtained from the Athens Institute of Environmental Pollution (1993). 
In the present study, a trend for female pre- 
ponderance is noticeable, and this is also in 
accordance with data in the literature (11). 
In recent years, an increase in asthma preva- 
lence and severity has been witnessed world-wide 
(3,4,12). There is debate as to whether pollution is 
one of the major risk factors (13,14). Many 
studies have shown that exposure to NO,, SO,, 
particulate matter and acid aerosols increases 
symptoms of asthma arrd hospital admissions 
(7,15,16). Pollution may also lead to augmented 
allergenicity of allergens (17). Although Athens is 
a highly polluted city (Tables 4 and 5) (IS), the 
present study does not show a high prevalence of 
self-reported asthma in relation to other centres. 
However, it was not possible to ascertain 
whether the prevalence of asthma in Athens has 
increased because of pollution, since no other 
similar study has previously been performed in 
Greece. 
Apart from pollution, allergen exposure may 
be another significant risk factor for the devel- 
opment of asthma (19). Children are sensitized 
to house dust and house dust mite very early in 
life (20,21), and according to some researchers, 
this may be one reason for increased asthma 
prevalence (22). A steep rise in prevalence 
has been noted in countries such as England, 
Australia and New Zealand (5) with high hu- 
midity and housing styles that have changed 
in the last decades to include indoor tempera- 
ture increase with central heating, wall-to-wall 
carpets, restriction of ventilation with double 
glazing, and use of certain types of air condition- 
ing; conditions that enable house dust mites to 
thrive. Living-in pets are another important 
source of allergen. In Greece, wall-to-wall 
carpets are practically non-existent, pets in the 
house are infrequent and the climate in Athens is 
very dry and warm so windows are open for 
most of the year. 
ECRHS Stage II results (8) on environmental 
risk factors, bronchial hyper-reactivity and atopy 
may further illuminate the relationship between 
risk factors and asthma. It may also help define 
whether particular symptoms are predictive or 
indicative of true asthma. Repeated clinical 
check-ups and examination of biopsy specimens 
can possibly be more reliable in confirming the 
disease and in estimating real asthma prevalence. 
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